Product Description: 
The KLOW blend is a four-compound research formulation combining some of the most studied tissue repair and anti-inflammatory peptides into a single convenient stack. Each component targets complementary biological pathways — from local tissue repair to systemic regeneration and anti-inflammatory signaling — making KLOW one of the most comprehensive multi-peptide research formulations available at Peptide Resource Center.
 
Compound Breakdown
 
KPV (10mg) — A tripeptide derived from alpha-MSH studied for intestinal inflammation, gut mucosal healing, and NF-κB pathway inhibition. Targets inflammatory signaling at the cellular level.
 
BPC-157 (10mg) — A 15 amino acid peptide with over 180 published studies focused on tendon and ligament repair, gastrointestinal healing, and angiogenesis. Works locally at the site of tissue damage.
 
TB-500 (10mg) — A synthetic Thymosin Beta-4 fragment studied for systemic tissue repair, actin regulation, and new blood vessel development. Complements BPC-157 through systemic rather than local repair mechanisms.
 
GHK-Cu (50mg) — A copper peptide complex studied for wound healing, collagen synthesis, anti-inflammatory activity, and gene expression modulation across over 4,000 human genes.
 
Why Researchers Choose KLOW 
The four compounds in KLOW target tissue repair through four distinct but complementary mechanisms — local repair (BPC-157), systemic repair (TB-500), inflammation control (KPV), and regenerative gene expression (GHK-Cu). This multi-pathway approach makes KLOW a compelling formulation for comprehensive tissue repair and recovery research.
 
Specifications: KPV 10mg / BPC-157 10mg / TB-500 10mg / GHK-Cu 50mg | Lyophilized powder | Purity ≥98% | Store at 2–8°C
 
For Research Use Only. Not intended for human or veterinary use.